AZN icon

AstraZeneca

1,391 hedge funds and large institutions have $45.2B invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with 256 funds opening new positions, 497 increasing their positions, 410 reducing their positions, and 119 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,391
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$597M
Puts
$420M
Net Calls
Net Calls Change

Top Buyers

1 +$420M
2 +$412M
3 +$327M
4
Citigroup
Citigroup
New York
+$204M
5
Barclays
Barclays
United Kingdom
+$180M

Top Sellers

1 -$924M
2 -$831M
3 -$550M
4
Primecap Management
Primecap Management
California
-$258M
5
Citadel Advisors
Citadel Advisors
Florida
-$241M
Name Holding Trade Value Shares
Change
Change in
Stake
EGM
1426
Engineers Gate Manager
New York
LIP
1427
Lighthouse Investment Partners
Florida
Optiver Holding
1428
Optiver Holding
Netherlands
GIC
1429
Generali Investments CEE
Czech Republic
NSEDCP
1430
NJ State Employees Deferred Compensation Plan
New Jersey
P
1431
Pitcairn
Pennsylvania
BHCM
1432
Brevan Howard Capital Management
Jersey
CLGM
1433
Capitolis Liquid Global Markets
New York
LFA
1434
Legacy Financial Advisors
Kentucky
SMH
1435
Sanders Morris Harris
Texas
MIP
1436
Marietta Investment Partners
Wisconsin
SN
1437
Sittner & Nelson
Oregon
BFM
1438
Boothbay Fund Management
New York
WWM
1439
Whalen Wealth Management
Nevada
RCA
1440
Riverview Capital Advisers
Massachusetts
HSA
1441
HBK Sorce Advisory
Pennsylvania
OAC
1442
OMERS Administration Corp
Ontario, Canada
CT
1443
Coastline Trust
Rhode Island
HCM
1444
Howland Capital Management
Massachusetts
BFS
1445
Bradley Foster & Sargent
Connecticut
PP
1446
Prospector Partners
Connecticut
BJL
1447
Brighton Jones LLC
Washington
CAM
1448
CenterStar Asset Management
Illinois
SM
1449
Stonegate Management
Illinois
CW
1450
CreativeOne Wealth
Kansas